B Capital
VC Fund
Manhattan Beach, United States
B Capital is a VC fund in Manhattan Beach focused on Artificial Intelligence and Software. B Capital Group supports entrepreneurs building technology companies with a focus on start-ups aiming to scale internationally. The company partners with Boston Consulting Group and its incubation arm, BCG Digital Ventures, to help connect start-ups with corporations across various industries. B Capital Group maintains a portfolio of B2B and B2B2Ccompanies operating in multiple sectors and regions. It provides support in areas such as business development, capital raising, and organizational growth during key stages of company expansion.
- Total investments:
- 352
- Last investment:
- Lead investor:
- 48%
- Fund size:
- $500M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries B Capital invests in
Stages B Capital invests in
Countries B Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 24 contacts → | |||
Round size
- Seed
- $2M–$13M
- Series A
- $7.3M–$85M
- Series B
- $14M–$125M
Investment Focus
Industry
- Artificial Intelligence 57 (16%)
- Software 52 (15%)
- Health Care 50 (14%)
- SaaS 35 (10%)
- Information Technology 31 (9%)
Stage
- Series B 62 (18%)
- Series A 59 (17%)
- Seed 45 (13%)
- Series C 41 (12%)
- Series D 25 (7%)
Country
- United States 138 (39%)
- India 20 (6%)
- China 14 (4%)
- Singapore 10 (3%)
- Indonesia 8 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Allen Duan
General Partner
|
General Partner | Total investments: 2 | Find email | |
Daisy Cai
General Partner
|
General Partner | Total investments: 4 | Find email | |
Kabir Narang
Founding General Partner
|
Founding General Partner | Total investments: 47 | Find email | |
Karen Page
General Partner
|
General Partner | Total investments: 36 | Find email | |
Kelly Qiao
Senior Principal
|
Senior Principal | Total investments: 0 | Find email | |
| See all 24 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $33M / Series B / Sep 29, 2026 | ||
| Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable ofprocessing large amounts of data.The company was founded in 2021 and is based in New York. | $250M / Series D / Sep 24, 2026 | ||
| TeRAM creates state-of-the-art tailored 3D SRAM for frontier AI deployments, ranging from edge devices to data centers. | $37M / Seed / Sep 10, 2026 | ||
| NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders. | $80M / Series B / Sep 03, 2026 | ||
| Alpha Design AI is reinventing semiconductor design and verification through advanced AI agent techniques. Alpha Design AI is pioneering an AI-native approach to Electronic Design Automation (EDA), transforming how chips are designed and verified. Our flagship product, ChipAgents, aims to boost RTL design and verification productivity by 10x,driving innovation across industries with smarter, more efficient chip design. | $60M / Series A / Jul 29, 2026 | ||
| Flourish Health is a medical center that treats high-acuity mental health conditions including PTSD, depressive, and serious mood disorders. | $26M / Series A / Jul 27, 2026 | ||
| FlowGPT is a LLM prompt platform that allows anyone to explore, use, and share prompts across different LLMs. On FlowGPT, users can find high-quality prompts and their potential use cases. It is also an open-source community, a "Github" for prompt creators to collaborate, iterate, and manage their prompts. | $60M / Series B / Jul 08, 2026 | ||
| Grace Investment Machine is a next-generation, self-evolving intelligent agent investment platform designed to continuously learn from market dynamics, adapt its strategies in real time, and deliver data-driven insights that help investors optimize portfolio performance, manage risk effectively, and make smarter, faster investment decisions in anever-changing financial landscape. | Series A / Jun 25, 2026 | ||
| Web Search Engine | $12.5M / Seed / Jun 24, 2026 | ||
| Cadence is a healthcare technology company that provides remote patient care and chronic disease management services for health systems and providers. It operates a clinical AI-driven platform that monitors patients at home and supports ongoing treatment for conditions such as hypertension, diabetes, and heart failure through connected devices,data tracking, and clinician-led care workflows. The company’s model centers on continuous monitoring of patient vitals like blood pressure, weight, symptoms, and medication adherence, with data flowing into a clinical intelligence system that flags risks and supports early intervention. | $100M / Series C / Jun 23, 2026 | ||
| See all 352 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does B Capital invest in?
B Capital invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Series B and Series A stage. Most of the 352 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is B Capital's check size?
B Capital typically joins rounds of $2M–$13M at Seed, $7.3M–$85M at Series A and $14M–$125M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds B Capital participates in.
How do I contact B Capital?
Public channels for B Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at B Capital?
The team at B Capital includes Allen Duan (General Partner), Daisy Cai (General Partner) and Kabir Narang (Founding General Partner), among 24 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
